论文部分内容阅读
采用临床药代动力学数据，用对比分析的方法确定了胸腺肽降压物质测定中胸腺肽的给药剂量，并对6批静脉滴注用胸腺肽进行了降压物质测定，均符合规定。
Clinical pharmacokinetic data were used to determine the dosage of thymosin in the determination of thymosin antihypertensive substances by the method of comparative analysis, and the determination of antihypertensive substances by thymosin in six batches of intravenous drip was performed, which were in line with the regulations.